It is expected that as digital microfluidic biochips (DMFBs) mature, the hardware design flow will begin to resemble the current practice in the semiconductor industry: design teams send chip layouts to third party foundries for fabrication. These foundries are untrusted, and threaten to steal valuable intellectual property (IP). In a DMFB, the IP consists of not only hardware layouts, but also of the biochemical assays (bioassays) that are intended to be executed on-chip. DMFB designers therefore must defend these protocols against theft. We propose to 'lock' biochemical assays through random insertion of dummy mix-split operations, subject to several design rules. We experimentally evaluate the proposed locking mechanism, and show how a high level of protection can be achieved even on bioassays with low complexity. We offer guidance on the number of dummy mixsplits required to secure a bioassay for the lifetime of a patent.